Most pts w/ liver mets presented w/ elevated AST (52%) or ALP (56%) while fewer pts had elevations in ALT (29%) or total bilirubin (15%)
1137-A LONG-TERM OUTCOMES OF LIVER TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA: A MULTICENTER COHORT STUDY Heechul Nam 1 , Pil Soo Sung 2 , Hee Yeon Kim 1 , Ho Joong Choi 1 , Jung Hyun Kwon 1 , U Im Chang 1 , Chang Wook Kim 1 , Si Hyun Bae 1 , Young Kyoung You 1 , Jong Choi 1 , Seung Kew Yoon 1 , Jin Mo Yang 1 and Jeong Won Jang 1 , (1)The Catholic University of Korea, (2)The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, the Catholic University of Korea Background: Recent guidelines recommend that liver transplantation (LT) can be considered for patients with hepatocellular carcinoma (HCC) that exceeds Milan criteria (MC) if they have been successfully downstaged to within MC
atRAL, all-transretinal
[511] also endorse the need for multi-center and multimodal investigations to individualize and elucidate unique signatures and biomarkers of neurophysiological underpinnings and delineate biologically and clinically meaningful subgroups of ASD
These OH radicals can directly attack PUFAs, such as linoleic acid and arachidonic acid, in cell membranes
Fecal LCN2 (FLCN2) exhibits diagnostic performance comparable to fecal calprotectin (FCAL), with both markers significantly elevated during inflammatory flares and normalized in deep remission (reaching levels indistinguishable from those in healthy controls) (Zollner et al
